222 related articles for article (PubMed ID: 24005194)
61. RhBMP-2 use in lumbar fusion surgery is associated with transient immediate post-operative leg pain.
Rowan FE; O'Malley N; Poynton A
Eur Spine J; 2012 Jul; 21(7):1331-7. PubMed ID: 22167451
[TBL] [Abstract][Full Text] [Related]
62. Comparison of best versus worst clinical outcomes for adult spinal deformity surgery: a retrospective review of a prospectively collected, multicenter database with 2-year follow-up.
Smith JS; Shaffrey CI; Lafage V; Schwab F; Scheer JK; Protopsaltis T; Klineberg E; Gupta M; Hostin R; Fu KM; Mundis GM; Kim HJ; Deviren V; Soroceanu A; Hart RA; Burton DC; Bess S; Ames CP;
J Neurosurg Spine; 2015 Sep; 23(3):349-59. PubMed ID: 26047345
[TBL] [Abstract][Full Text] [Related]
63. Transforaminal lumbar interbody fusion versus anterior lumbar interbody fusion as an adjunct to posterior instrumented correction of degenerative lumbar scoliosis: three year clinical and radiographic outcomes.
Crandall DG; Revella J
Spine (Phila Pa 1976); 2009 Sep; 34(20):2126-33. PubMed ID: 19752698
[TBL] [Abstract][Full Text] [Related]
64. The Lenke classification of adolescent idiopathic scoliosis: how it organizes curve patterns as a template to perform selective fusions of the spine.
Lenke LG; Edwards CC; Bridwell KH
Spine (Phila Pa 1976); 2003 Oct; 28(20):S199-207. PubMed ID: 14560193
[TBL] [Abstract][Full Text] [Related]
65. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
Hiremath GK; Steinmetz MP; Krishnaney AA
Spine (Phila Pa 1976); 2009 Apr; 34(9):885-9. PubMed ID: 19531997
[TBL] [Abstract][Full Text] [Related]
66. Safety, efficacy, and dosing of recombinant human bone morphogenetic protein-2 for posterior cervical and cervicothoracic instrumented fusion with a minimum 2-year follow-up.
Hamilton DK; Smith JS; Reames DL; Williams BJ; Chernavvsky DR; Shaffrey CI
Neurosurgery; 2011 Jul; 69(1):103-11; discussion 111. PubMed ID: 21368688
[TBL] [Abstract][Full Text] [Related]
67. Osteolysis in transforaminal lumbar interbody fusion with bone morphogenetic protein-2.
Knox JB; Dai JM; Orchowski J
Spine (Phila Pa 1976); 2011 Apr; 36(8):672-6. PubMed ID: 21217443
[TBL] [Abstract][Full Text] [Related]
68. The Risk of Cancer With the Use of Recombinant Human Bone Morphogenetic Protein in Spine Fusion.
Dettori JR; Chapman JR; DeVine JG; McGuire RA; Norvell DC; Weiss NS
Spine (Phila Pa 1976); 2016 Aug; 41(16):1317-1324. PubMed ID: 27261568
[TBL] [Abstract][Full Text] [Related]
69. Longer follow-up continues to reveal no increased risk of cancer with the use of recombinant human bone morphogenetic protein in spine fusion.
Dettori JR; Chapman JR; DeVine JG; McGuire RA; Junge MR; Norvell DC
Spine J; 2019 Oct; 19(10):1640-1647. PubMed ID: 31108234
[TBL] [Abstract][Full Text] [Related]
70. Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes.
Kleeman TJ; Ahn UM; Talbot-Kleeman A
Spine (Phila Pa 1976); 2001 Dec; 26(24):2751-6. PubMed ID: 11740368
[TBL] [Abstract][Full Text] [Related]
71. rhBMP use in cervical spine surgery: associated factors and in-hospital complications.
Jain A; Hassanzadeh H; Strike SA; Skolasky RL; Riley LH
J Bone Joint Surg Am; 2014 Apr; 96(8):617-23. PubMed ID: 24740657
[TBL] [Abstract][Full Text] [Related]
72. Multiple-day drainage when using bone morphogenic protein for long-segment thoracolumbar fusions is associated with low rates of wound complications.
Saulle D; Fu KM; Shaffrey CI; Smith JS
World Neurosurg; 2013; 80(1-2):204-7. PubMed ID: 22929109
[TBL] [Abstract][Full Text] [Related]
73. Treatment of pediatric spinal deformity with use of recombinant human bone morphogenetic protein-2.
Stiel N; Stuecker R; Kunkel P; Ridderbusch K; Hagemann C; Breyer S; Ebert N; Spiro AS
J Mater Sci Mater Med; 2018 Jun; 29(7):93. PubMed ID: 29938328
[TBL] [Abstract][Full Text] [Related]
74. Complications related to osteobiologics use in spine surgery: a systematic review.
Mroz TE; Wang JC; Hashimoto R; Norvell DC
Spine (Phila Pa 1976); 2010 Apr; 35(9 Suppl):S86-104. PubMed ID: 20407355
[TBL] [Abstract][Full Text] [Related]
75. Factors associated with use of bone morphogenetic protein during pediatric spinal fusion surgery: an analysis of 4817 patients.
Jain A; Kebaish KM; Sponseller PD
J Bone Joint Surg Am; 2013 Jul; 95(14):1265-70. PubMed ID: 23864174
[TBL] [Abstract][Full Text] [Related]
76. Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2).
Cooper GS; Kou TD
Spine (Phila Pa 1976); 2013 Oct; 38(21):1862-8. PubMed ID: 23883824
[TBL] [Abstract][Full Text] [Related]
77. Insights into complication rates, reoperation rates, and healthcare utilization associated with use of recombinant human bone morphogenetic protein-2 in patients with spine infections.
Sharma M; Dietz N; Alhourani A; Ugiliweneza B; Wang D; Drazin D; Boakye M
Neurosurg Focus; 2019 Jan; 46(1):E8. PubMed ID: 30611165
[TBL] [Abstract][Full Text] [Related]
78. Use of rhBMP-2 for adult spinal deformity surgery: patterns of usage and changes over the past decade.
Bannwarth M; Smith JS; Bess S; Klineberg EO; Ames CP; Mundis GM; Kim HJ; Lafage R; Gupta MC; Burton DC; Shaffrey CI; Schwab FJ; Lafage V;
Neurosurg Focus; 2021 Jun; 50(6):E4. PubMed ID: 34062501
[TBL] [Abstract][Full Text] [Related]
79. Lumbar interbody fusion with utilization of recombinant human bone morphogenetic protein: a retrospective real-life study about 277 patients.
Litrico S; Langlais T; Pennes F; Gennari A; Paquis P
Neurosurg Rev; 2018 Jan; 41(1):189-196. PubMed ID: 28281191
[TBL] [Abstract][Full Text] [Related]
80. The Effect of Smoking Status on Successful Arthrodesis After Lumbar Instrumentation Supplemented with rhBMP-2.
Macki M; Syeda S; Rajjoub KR; Kerezoudis P; Bydon A; Wolinsky JP; Witham T; Sciubba DM; Bydon M; Gokaslan Z
World Neurosurg; 2017 Jan; 97():459-464. PubMed ID: 27756663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
